Dopaminergic responsivity during cocaine abstinence: a pilot study.

Area of Science:

• Neuroscience
• Addiction Research
• Pharmacology

Background:

• Cocaine dependence is a significant public health issue.
• Understanding dopamine (DA) system function during abstinence is crucial for treatment development.
• Previous research suggests alterations in neurotransmitter systems following chronic substance use.

Purpose of the Study:

• To investigate dopamine (DA) function in individuals during early and late cocaine abstinence.
• To assess the neuroendocrine and biochemical responses to L-dopa/carbidopa (Sinemet) administration during different abstinence phases.
• To determine if DA responsivity changes over the course of cocaine abstinence.

Main Methods:

• A preliminary study involving six hospitalized cocaine-dependent subjects.
• Administration of active cocaine followed by a placebo period.
• Measurement of plasma growth hormone (GH), homovanillic acid (HVA), prolactin, and 3-methoxy-4-hydroxyphenethyleneglycol.
• Placebo-controlled administration of oral L-dopa/carbidopa (Sinemet) during early and late abstinence.

Main Results:

• Sinemet administration led to significantly greater placebo-corrected increases in GH and HVA during early abstinence compared to late abstinence.
• These findings suggest enhanced dopamine (DA) system responsivity in acute cocaine abstinence.
• The observed differences in GH and HVA responses indicate a normalization of DA function over time.

Conclusions:

• Acute cocaine abstinence is associated with increased dopamine (DA) system responsivity.
• Dopamine (DA) function appears to normalize with sustained abstinence from cocaine.
• These findings have implications for understanding the neurobiological underpinnings of addiction and withdrawal.